#lecanemab

Live, measured metrics for the hashtag #lecanemab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #lecanemab

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$51.02/ year · 9-character #name
Claim #lecanemab — $51.02/yr→
Annual, renews each year
Buy on hashtag.space (web3)
one-timepay once, yours for life
card via hashtag.org · tokens via hashtag.space
1
Uses / 7 days
Mastodon
1
Accounts / 7 days
Mastodon
40
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 40
0
Avg reactions / post
Mastodon · last 40

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-07-27 05:53 UTC
1
07-21
0
07-22
0
07-23
0
07-24
0
07-25
0
07-26
0
07-27

1 uses by 1 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-07-27 05:53 UTC
#lecanemabe
0 uses · 0 accounts / 7d

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-07-27 05:53 UTC

Everything below is measured over the latest 40 public posts (spanning ~28175 hours).

Posting hours (UTC) — busiest: 07:00

00:0012:0023:00

Languages: English (23) · German (14) · Dutch (1) · Finnish (1) · Chinese (1)

Avg boosts / post: 0.9

Top of the latest posts

  • A team of scientists in Japan has identified the "seed" of a protein believed to trigger Alzheimer's disease, a discovery boosting hope for the development of a new therapy for the neurodegenerative condition. https://www.japantimes.co.jp/n

    The Japan Times@[email protected]♥ 0↻ 52026-07-21 11:56 UTCView post →

  • Neue Alzheimer-Medikamente wecken große Hoffnungen. Doch bei Lecanemab und Donanemab fällt die Nutzen-Schaden-Bilanz kritisch aus. Inzwischen sind beide Wirkstoffe in Deutschland auf dem Markt. Die Bewertung des tatsächlichen Nutzens und de

    BUKO Pharma-Kampagne@[email protected]♥ 0↻ 02026-06-04 07:01 UTCView post →

  • Less than 20% of people in Japan who showed interest in new medications for Alzheimer's disease went on to receive one, mainly because they were not medically eligible or they decided against it for fear of side effects. https://www.japanti

    The Japan Times@[email protected]♥ 0↻ 02026-04-08 13:38 UTCView post →

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/lecanemab